Blood pressure medication combined with chemotherapy could reduce spread in triple negative breast cancer

by

A new international study led by Monash University has, for the first time, identified that beta-blockers could significantly enhance the therapeutic effect of anthracycline chemotherapy in triple negative breast cancer (TNBC) by reducing metastasis.

Leave A Comment

Your email address will not be published. Required fields are marked *